Company

Lmito Therapeutics

Biotechnology Research Not Only #cmt1a but Also Other Neuroinflammatory and Demyelinating Conditions Such as Rheumatoid Arthritis and Ankylosing Spondylitis. 8 employees

Employees: 8
Contacts: 1
Emails: 1

www.lmito.com LinkedIn Crunchbase

Lmito Therapeutics Overview

Headquarters: Not Only #cmt1a but Also Other Neuroinflammatory and Demyelinating Conditions Such as Rheumatoid Arthritis and Ankylosing Spondylitis.
Website: www.lmito.com
Industry: Biotechnology Research
Employees: 8
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Lmito Therapeutics

Lmito develops a novel therapy for autoimmune disorders through a modulation of immunometabolism including a macrophage polarization. In the fibrotic context, LMT compounds exert the anti-fibrotic effects through metabolic reprogramming of profibrotic cells in PF-ILD and IPF.

Lmito Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Lmito Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Eunju Lee	Co-founder & COO at Lmito - Jlabs Korea	South Korea, United States	View
Wheeseong Lee	CEO / Founder at Lmito Therapeutics		View
Jundong Kim	Lmito Therapeutics, Management Support	Seoul, South Korea, Korea, Republic of	View
Namkyu Lee	Vice President/research Fellow at Lmito	South Korea, Korea, Republic of	Email